HLA-DR2 PREDICTS A FAVORABLE RESPONSE TO CYCLOSPORINE THERAPY IN PATIENTS WITH BONE-MARROW FAILURE

被引：19

作者：

NAKAO, S

YAMAGUCHI, M

SAITO, M

YASUE, S

SHIOBARA, S

MATSUDA, T

NITTA, M

SASAKI, M

机构：

[1] KANAZAWA UNIV,SCH MED,BLOOD TRANSFUS SECT,KANAZAWA,ISHIKAWA 920,JAPAN

[2] ISHIKAWA RED CROSS BLOOD CTR,KANAZAWA,ISHIKAWA,JAPAN

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 1992年 / 40卷 / 03期

关键词：

D O I：

10.1002/ajh.2830400319

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：239 / 240

页数：2

共 6 条

[1] THE RELATION BETWEEN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTION AND THE CAPACITY OF IA TO BIND IMMUNOGENIC PEPTIDES [J].

BUUS, S ;

SETTE, A ;

COLON, SM ;

MILES, C ;

GREY, HM .

SCIENCE, 1987, 235 (4794) :1353-1358

[2] INCREASED FREQUENCY OF DR2 IN PATIENTS WITH APLASTIC-ANEMIA AND INCREASED DR SHARING IN THEIR PARENTS [J].

CHAPUIS, B ;

VONFLIEDNER, VE ;

JEANNET, M ;

MERICA, H ;

VUAGNAT, P ;

GRATWOHL, A ;

NISSEN, C ;

SPECK, B .

BRITISH JOURNAL OF HAEMATOLOGY, 1986, 63 (01) :51-57

[3] CYCLOSPORINE THERAPY OF APLASTIC-ANEMIA, CONGENITAL AND ACQUIRED RED-CELL APLASIA [J].

LEONARD, EM ;

RAEFSKY, E ;

GRIFFITH, P ;

KIMBALL, J ;

NIENHUIS, AW ;

YOUNG, NS .

BRITISH JOURNAL OF HAEMATOLOGY, 1989, 72 (02) :278-284

[4]

REES AJ, 1978, LANCET, V1, P966

[5] LYMPHOCYTE-B ALLOANTIGENS ASSOCIATED WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].

REINERTSEN, JL ;

KLIPPEL, JH ;

JOHNSON, AH ;

STEINBERG, AD ;

DECKER, JL ;

MANN, DL .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (10) :515-518

[6] DOES HLA-DR PREDICT RESPONSE TO SPECIFIC IMMUNOSUPPRESSIVE THERAPY IN APLASTIC-ANEMIA [J].

RUGMAN, FP ;

ASHBY, D ;

DAVIES, JM .

BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (04) :545-546

← 1 →